Maria-christina Jung
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R).
Journal: Zeitschrift fur Gastroenterologie
Published: September 18, 2020
Risk factors for resistance development against lamivudine during long-term treatment of chronic hepatitis B virus infections.
Journal: European journal of gastroenterology & hepatology
Published: February 22, 2019
Chronic Hepatitis C - Therapeutic Options in 2016
Journal: MMW Fortschritte der Medizin
Published: June 05, 2016
Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction.
Journal: The Journal of experimental medicine
Published: September 17, 2014
Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules.
Journal: PloS one
Published: May 16, 2014
Lack of variant specific CD8+ T-cell response against mutant and pre-existing variants leads to outgrowth of particular clones in acute hepatitis C.
Journal: Virology journal
Published: April 25, 2013
Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 21, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026